SEMA3A Gene

SEMA3A — Semaphorin 3A

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SEMA3A Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SEMA3A</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>SEMA3A</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=SEMA3A" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Introduction

Sema3A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

...

SEMA3A — Semaphorin 3A

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SEMA3A Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SEMA3A</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>SEMA3A</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=SEMA3A" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Introduction

Sema3A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

SEMA3A encodes semaphorin 3A, a secreted class 3 semaphorin that functions as a context-dependent guidance and patterning cue in the developing and adult nervous system.[@tran2018][@pasterkamp2012] Rather than acting as a simple "repellent," SEMA3A tunes neurite extension, dendritic patterning, spine maturation, and synaptic remodeling based on receptor composition and local signaling state.[@tran2018][@van2015] In neurodegeneration, this guidance logic is relevant because axon terminals, dendritic arbors, and glial barriers are repeatedly remodeled in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis).[@selkoe2016][@poewe2017]

Gene And Protein Context

The SEMA3A gene lies on chromosome 7p12 and encodes a secreted glycoprotein with a canonical sema domain, PSI domain, and basic C-terminal region that supports receptor engagement and extracellular matrix interactions.[@tran2018][@pasterkamp2012] After secretion, semaphorin 3A signals through receptor complexes assembled from neuropilins and plexins, especially neuropilin-1 with class A plexins.[@tran2018][@van2015] This architecture enables high spatiotemporal precision: local ligand availability, receptor stoichiometry, and downstream second-messenger states decide whether growth cones collapse, stabilize, or reorient.[@tran2018][@goshima2016]

In mature circuits, semaphorin signaling persists outside developmental windows. Cortical and hippocampal systems reuse semaphorin-plexin modules for synaptic pruning, activity-dependent plasticity, and homeostatic rewiring after stress.[@van2015][@yoshida2012] Those same processes are stressed in tauopathy, synucleinopathy, and proteinopathy states, making SEMA3A mechanistically relevant even when it is not a primary Mendelian disease gene.[@selkoe2016][@poewe2017]

Cellular Mechanisms

Axon Guidance And Cytoskeletal Control

SEMA3A triggers signaling cascades that converge on actin and microtubule regulators, translating extracellular guidance information into growth cone behavior.[@tran2018][@goshima2016] Rho-family GTPase balance, cofilin activity, and local microtubule dynamics are key effectors, linking SEMA3A to a broader cytoskeletal vulnerability axis seen across neurodegenerative disorders.[@goshima2016][@taylor2016] Because axonal maintenance is energy-demanding, semaphorin-driven remodeling can become maladaptive in [neurons](/entities/neurons) already burdened by mitochondrial stress or impaired proteostasis.[@poewe2017][@taylor2016]

Synaptic Plasticity And Circuit Refinement

In hippocampal and cortical networks, semaphorin signaling helps calibrate synapse density and dendritic structure.[@van2015][@yoshida2012] This is functionally important for memory systems affected early in [Alzheimer's disease](/diseases/alzheimers-disease), where dendritic spine loss and dysfunctional network scaling precede broad neuronal death.[@selkoe2016][@dekosky1990] A practical interpretation is that altered SEMA3A tone may amplify existing synaptic fragility, especially in circuits with heavy activity-dependent remodeling loads.

Neuroimmune And Vascular Interfaces

Semaphorin family members also influence endothelial and immune-cell behavior, so SEMA3A signaling can intersect with [blood-brain barrier](/entities/blood-brain-barrier) integrity and inflammatory trafficking.[@worzfeld2014][@takamatsu2012] These interfaces are central in chronic neurodegeneration, where microglial activation and vascular dysfunction shape progression speed and regional vulnerability.[@worzfeld2014][@sweeney2018]

Relevance To Neurodegenerative Disease

Alzheimer's Disease

AD progression includes early synaptic failure, dendritic simplification, and chronic glial activation.[@selkoe2016][@dekosky1990] SEMA3A-linked guidance and pruning programs can interact with these features by shifting structural plasticity thresholds and neurite stability in vulnerable cortical and hippocampal regions.[@van2015][@selkoe2016] Although SEMA3A is not a core amyloid-processing gene, its pathway-level effects are coherent with AD mechanisms involving circuit disconnection and maladaptive remodeling.[@selkoe2016][@yoshida2012]

Parkinson's Disease

Nigrostriatal degeneration in [Parkinson's disease](/diseases/parkinsons-disease) includes axonal and synaptic failure before extensive cell body loss.[@poewe2017][@surmeier2017] Guidance-cue signaling, including semaphorin pathways, is therefore relevant to dopaminergic axon maintenance and compensatory sprouting limits.[@poewe2017][@surmeier2017] This framework also connects SEMA3A biology to non-motor network dysfunction, where circuit-level remodeling extends beyond the substantia nigra.

ALS And Motor System Disorders

Motor neuron diseases require analysis of axon length burden, cytoskeletal resilience, and neuron-glia signaling.[@taylor2016][@van2017] SEMA3A-associated pathways intersect all three domains, supporting investigation of whether guidance-cue imbalance contributes to corticospinal and spinal motor circuit vulnerability in [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis).[@taylor2016][@van2017]

Translational Implications

SEMA3A is best treated as a pathway-modifier target rather than a standalone disease switch. Three translational uses are most plausible:[@van2015][@worzfeld2014]

Biomarker context: integrate semaphorin pathway readouts with synaptic and inflammatory biomarkers to stratify remodeling-prone disease states.

Combination therapy logic: pair circuit-stabilizing interventions with anti-inflammatory or proteostasis-targeted therapies rather than monotherapy aimed only at guidance signaling.

Cell-type precision: prioritize region- and cell-specific modulation strategies because semaphorin effects differ by receptor composition and disease stage.

See Also

• [Axon Guidance](/mechanisms/axon-guidance)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)

Background

The study of Sema3A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

[Tran TS, Kolodkin AL, Bharadwaj R, Semaphorin regulation of cellular morphology (2018)](https://doi.org/10.1146/annurev-cellbio-100617-062834)

[Pasterkamp RJ, Getting neural circuits into shape with semaphorins (2012)](https://doi.org/10.1038/nrn3309)

[Van Battum EY, Brignani S, Pasterkamp RJ, Axon guidance proteins in neurological disorders (2015)](https://doi.org/10.1016/j.tins.2015.02.008)

[Selkoe DJ, Hardy J, The amyloid hypothesis of Alzheimer's disease at 25 years (2016)](https://doi.org/10.1016/S0140-6736(16)

[Poewe W, Seppi K, Tanner CM, et al, Parkinson disease (2017)](https://doi.org/10.1038/nrdp.2017.13)

[Goshima Y, Sasaki Y, Nakayama T, Ito T, Kimura T, Functions of semaphorins in axon guidance and neuronal regeneration (2016)](https://doi.org/10.3389/fncel.2016.00023)

[Yoshida Y, Semaphorin signaling in vertebrate neural circuit assembly (2012)](https://doi.org/10.3389/fnmol.2012.00071)

[Taylor JP, Brown RH Jr, Cleveland DW, Decoding ALS: from genes to mechanism (2016)](https://doi.org/10.1038/nature20413)

[DeKosky ST, Scheff SW, Synapse loss in frontal cortex biopsies in Alzheimer's disease (1990)](https://pubmed.ncbi.nlm.nih.gov/8724060/)

[Worzfeld T, Offermanns S, Semaphorins and plexins as therapeutic targets (2014)](https://doi.org/10.1038/nrd4337)

[Takamatsu H, Kumanogoh A, Diverse roles for semaphorin-plexin signaling in the immune system (2012)](https://doi.org/10.1016/j.tcb.2012.04.008)

[Sweeney MD, Sagare AP, Zlokovic BV, Blood-brain barrier breakdown in Alzheimer disease (2018)](https://doi.org/10.1038/nrneurol.2018.188)

[Surmeier DJ, Obeso JA, Halliday GM, Selective neuronal vulnerability in Parkinson disease (2017)](https://doi.org/10.1038/nrn3890)

[Van Damme P, Robberecht W, Van Den Bosch L, Modelling neurodegenerative diseases in model organisms (2017)](https://doi.org/10.1016/j.bbadis.2017.03.009)